Steven Batash MD PC / Batash Endoscopic Weight Loss
97-12 63rd Drive · Queens, NY 11374
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
97-12 63rd Drive · Queens, NY 11374
32-72 Steinway Street · Queens, NY 11103
4.0(884 Google reviews · 87 in past year)
37-20 76th Street · Queens, NY 11372
4.9(619 Google reviews · 96 in past year)
104-02 Rockaway Beach Boulevard · Queens, NY 11694
5.0(519 Google reviews · 30 in past year)
68-60 108th Street · Queens, NY 11375
4.9(323 Google reviews · 46 in past year)
115-12 Queens Boulevard · Queens, NY 11375
4.9(251 Google reviews · 55 in past year)
98-11 Queens Boulevard · Queens, NY 11374
5.0(222 Google reviews · 71 in past year)
106-15 Queens Boulevard · Queens, NY 11375
4.9(153 Google reviews · 18 in past year)
158-01 Cross Bay Boulevard · Queens, NY 11414
4.0(100 Google reviews · 37 in past year)
38-08 Union Street · Queens, NY 11354
4.9(82 Google reviews · 35 in past year)
134-48 Blossom Avenue · Queens, NY 11355
5.0(55 Google reviews · 20 in past year)
23-18 31st Street · Queens, NY 11105
3.5(54 Google reviews · 11 in past year)
105-09 Metropolitan Avenue · Queens, NY 11375
5.0(48 Google reviews · 45 in past year)
70-64 Yellowstone Boulevard · Queens, NY 11375
4.9(43 Google reviews · 14 in past year)
Pins reflect street addresses where available; others are approximate (ZIP-level).
Be first to know when its status changes — join thousands already on the list.
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Queens or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 3 of the 29 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve New York residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.